The GH1/IGF-1 axis polymorphisms and their impact on breast cancer development Kerstin WagnerKari HemminkiAsta Försti Review Paper 02 November 2006 Pages: 233 - 248
In vivo proton magnetic resonance spectroscopy of breast lesions: an update Gary M. TseDavid K. Y. YeungWei-Tse Yang Review Paper 19 October 2006 Pages: 249 - 255
Prediction of BRCA1 and BRCA2 mutation status using post-irradiation assays of lymphoblastoid cell lines is compromised by inter-cell-line phenotypic variability Paul K. LovelockEe Ming WongMichael J. McKay Preclinical Study 25 October 2006 Pages: 257 - 266
Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo Md. Zahidunnabi DewanHiroshi TerunumaNaoki Yamamoto Preclinical study 26 October 2006 Pages: 267 - 275
Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer Sarangadhara Appala Raju BagadiChandra Prakash PrasadRanju Ralhan Preclinical Study 18 November 2006 Pages: 277 - 286
CYP1A1 and CYP1B1 genetic polymorphisms, smoking and breast cancer risk in a Finnish Caucasian population Pia SillanpääLiisa HeikinheimoAri Hirvonen Epidemiology 25 October 2006 Pages: 287 - 297
Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks Anna JakubowskaJacek GronwaldUte Hamann Epidemiology 25 October 2006 Pages: 299 - 308
Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study Sandra L. DemingZefang RenWei Zheng Epidemiology 25 October 2006 Pages: 309 - 319
Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors Kristi D. GravesBeth N. PeshkinMarc D. Schwartz Epidemiology 26 October 2006 Pages: 321 - 329
Parental age at delivery and incidence of breast cancer: a prospective cohort study Fei XueGraham A. ColditzKarin B. Michels Epidemiology 18 November 2006 Pages: 331 - 340
Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer Maysa M. Abu-KhalafVinni JunejaBarbara A. Burtness Original Paper 19 October 2006 Pages: 341 - 349
BRCA1 disease-associated haplotypes in Singapore Malay women with early-onset breast/ovarian cancer A. B. AliP. T. IauJ. H. Sng Letter to the Editor 04 April 2007 Pages: 351 - 353